Prevenção Quaternária e limites em medicina*,**

Marc Jamoulle; Luís Filipe Gomes

doi:10.5712/rbmfc9(31)867

Authors

Marc Jamoulle Espace Temps maison de santé, Charleroi, family doctor, investigador em Cuidados Primários. Departement Universitiare de Médecine Générale of the Université de Liège (DUMG ULg).
Luís Filipe Gomes Universidade do Algarve (UAlg). Faro,

DOI:

https://doi.org/10.5712/rbmfc9(31)867

Keywords:

Conflict of Interest, Medicalization, Quaternary Prevention, Family Practice

Abstract

The concept of Quaternary Prevention, a questioning upon the basis of medical action, was born from the articulation of the doctor-patient relationship. It refers to all medical activities being an important tool for family medicine. It is an ethical question about the excesses of too much and too little medicine which provides some answers.

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

Author Biography

Marc Jamoulle, Espace Temps maison de santé, Charleroi, family doctor, investigador em Cuidados Primários. Departement Universitiare de Médecine Générale of the Université de Liège (DUMG ULg).

Family Practitioner. Health data management specialist.

References

World Psychiatric Association. A conceptual framework for the revision of the ICD-10 classification of mental and behavioural disorders. World Psychiatry. 2011;10(2):86-92. PMid:21633677 PMCid:PMC3104876. DOI: https://doi.org/10.1002/j.2051-5545.2011.tb00022.x

American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 5th ed. Arlington: APA; 2013. DOI: https://doi.org/10.1176/appi.books.9780890425596

Cosgrove L, Wheeler EE. Drug firms, the codification of diagnostic categories, and bias in clinical guidelines. J Law Med Ethics [Internet]. 2013;14(3):1-27. Disponível em: http://papers.ssrn.com/sol3/papers.cfm?abstract_id=2286724

St-Onge JC. Tous fous? L’influence de l’industrie pharmaceutique sur la psychiatrie. Montréal: Ecosociété; 2013.

Moynihan R, Heath I, Henry D. Selling sickness: the pharmaceutical industry and disease mongering. Br Med J. 2002;324(7342):886-891. http://dx.doi.org/10.1136/bmj.324.7342.886 DOI: https://doi.org/10.1136/bmj.324.7342.886

Fugh-Berman A, Ahari S. Following the script: how drug reps make friends and influence doctors. PLoS Med. 2007;4(4):e150. PMid:17455991 PMCid:PMC1876413. http://dx.plos.org/10.1371/journal.pmed.0040150 DOI: https://doi.org/10.1371/journal.pmed.0040150

Mintzes B, Lexchin J, Sutherland JM, Beaulieu MD, Wilkes MS, Durrieu G, et al. Pharmaceutical sales representatives and patient safety: a comparative prospective study of information quality in Canada, France and the United States. J Gen Intern Med. 2013;10:1368-1375. PMid:23558775. http://dx.doi.org/10.1007/s11606-013-2411-7 DOI: https://doi.org/10.1007/s11606-013-2411-7

Sah S, Fugh-Berman A. Physicians under the influence: social psychology and industry marketing strategies. J Law Med Ethics [Internet]. 2013;14(3):1-27. Disponível em: http://papers.ssrn.com/sol3/papers.cfm?abstract_id=2286433

Taylor F, Huffman MD, Macedo AF, Moore THM, Burke M, Smith GD, et al. Statins for the primary prevention of cardiovascular disease. Cochrane Database Syst Rev. 2013;1. http://dx.doi.org/10.1002/14651858.CD004816.pub5 DOI: https://doi.org/10.1002/14651858.CD004816.pub5

Cathébras P. [Doctor Knock lives at Wall Street. The new targets of pharmaceutical industry]. Rev Med Interne. 2003;24(8):538-41. PMid:12888175. Disponível em: http://www.ncbi.nlm.nih.gov/pubmed/12888175 DOI: https://doi.org/10.1016/S0248-8663(03)00195-4

Goldacre B, Bad pharma: how drug companies mislead doctors and harm patients. London: Faber & Faber; 2012

Parry V. The art of branding a condition. Med Mark Media [Internet]. 2003;38(5)43-49 Disponível em: http://www.ybranding.com/Content/pdf/TheArtofBrandingaCondition.pdf.

Heath I. Combating disease mongering: daunting but nonetheless essential. PLoS Medicine. 2006;3(4):e146. PMid:16597174 PMCid:PMC1434491. http://dx.doi.org/10.1371/journal.pmed.0030146 DOI: https://doi.org/10.1371/journal.pmed.0030146

Brownlee S. Overtreated: why too much medicine is making us sicker and poorer. USA: Bloomsbury; 2008.

Light DW, Lexchin J, Darrow JJ. Institutional Corruption of Pharmaceuticals and the Myth of Safe and Effective Drugs. J Law, Med Ethics. 2013;14(3):590-600. DOI: https://doi.org/10.1111/jlme.12068

Dumit J. Drugs for life. Durham: Duke University Press; 2012. PMCid:PMC3342335. http://dx.doi.org/10.1215/9780822393481 DOI: https://doi.org/10.1215/9780822393481

Welch HG, Schwartzl L, Woloshin S. Overdiagnosed. Boston: Beacon Press; 2011.

Morell Sixto, ME, Martínez González,C, Quintana Gómez, JL. Disease mongering, el lucrativo negocio de la promoción de enfermedades. Rev Pediatr Aten Primaria. 2009;11(43)491-512. http://dx.doi.org/10.4321/S1139-76322009000400011 DOI: https://doi.org/10.4321/S1139-76322009000400011

Moynihan R. A new deal on disease definition. Br Med J. 2011;342:d2548-d2548. PMid:21540259. http://dx.doi.org/10.1136/bmj.d2548 DOI: https://doi.org/10.1136/bmj.d2548

Zahl PH, Gøtzsche PC, Mæhlen J. Natural history of breast cancers detected in the Swedish mammography screening programme: a cohort study. Lancet Oncol [Internet]. 2011;12(12):1118-1124 [acesso em 2011 Oct 17]. PMid:21996169. Disponível em: http://www.ncbi.nlm.nih.gov/pubmed/21996169 DOI: https://doi.org/10.1016/S1470-2045(11)70250-9

Gøtzsche PC, Gotzsche PG. Mammography screening: truth, lies and controversy. Radcliffe Publishing [Internet]; 2012. p. 400. [acesso em 2012 Feb 3]. Disponível em: http://www.radcliffe-oxford.com/books/bookdetail.aspx?ISBN=1846195853

Meador CK. The art and science of non disease. New Engl J Med. 1965;14(272):92-95 http://dx.doi.org/10.1056/NEJM196501142720208 DOI: https://doi.org/10.1056/NEJM196501142720208

Smith R. In search of "non-disease". Br Med J. 2002;324(7342):883-885. http://dx.doi.org/10.1136/bmj.324.7342.883 DOI: https://doi.org/10.1136/bmj.324.7342.883

Barsky AJ, Borus JF. Functional somatic syndromes. Ann Intern Med. 1999;130(11):910-921. http://dx.doi.org/10.7326/0003-4819-130-11-199906010-00016 DOI: https://doi.org/10.7326/0003-4819-130-11-199906010-00016

Jamoulle M. Information et informatisation en médecine générale [Internet]. Belgium: Presses Universitaires de Namur; 1986. p. 193-209. Disponível em: http://www.ph3c.org/PH3C/docs/27/000103/0000405.pdf

Jamoulle M, Roland M. Prévention quaternaire De Wonca world Hong Kong 1995 à Wonca world Prague 2013. Wonca world Prague [Internet]. 2013. Poster. Disponível em: http://www.ph3c.org/PH3C/docs/27/000284/0000440.pdf.

Jamoulle M. A propos d'un dessin. Ethica Clinica [Internet]. 2013;70:28-31. Disponível em: http://www.ph3c.org/PH3C/docs/27/000281/0000416.pdf.

Illich I. Némésis médicale: l'expropriation de la santé. Paris: Seuil; 1975.

Carpentier J. Medical flipper. Paris: La Découverte; 1989. Cahiers libres, 402.

Balint M. The doctor, his patient, and the illness. Edinburgh: Churchill Livingstone; 1964.

McWhinney IR, Freeman T. A Textbook of family medicine. 2th ed. Oxford University Press; 1997.

Jamoulle M. Déclaration d'intention; Le médecin généraliste et de famille et l'usager de drogue [Internet]. 1997. Disponível em: http://www.ulb.ac.be/esp/mfsp/ethitox-fr.html

World Organization of National Colleges - WONCA International Classification Committtee. An international glossary for general/family practice. Fam Pract [Internet]. 1995;12(3):341-369. http://dx.doi.org/10.1093/fampra/12.3.341 DOI: https://doi.org/10.1093/fampra/12.3.341

Jamoulle M, Roland M. Quaternary prevention and the glossary of general practice/family medicine. Hong Kong: WICC; 1995.

Bentzen N. Wonca dictionary of general/family practice. Copenhagen: Wonca International Classification Committtee; 2003.